Physicians' Academy for Cardiovascular Education

Positive lesson from a negative trial comparing peri-operative continuation or interruption of DOAC therapy

AHA 2017 - Anaheim, CA, USA

Nov. 15, 2017 - AHA 2017 - Anaheim, CA - David H. Birnie, MD - Ottawa, ON, Canada

AHA 2017 BRUISE-CONTROL 1 showed an 80% reduction in device pocket hematoma with warfarin continuation vs bridging around device surgery. BRUISE-CONTROL 2 evaluated peri-procedural continuation vs interruption of DOACs. The study had a neutral outcome, still some important lessons can be drawn from it.

Educational information

This 3-minute education provides a summary of just presented scientific data, recorded during the AHA 2017 congress. The objective is to provide a brief commentary and potential implications of these findings.

Faculty

David H. Birnie, MD - University of Ottawa Heart Institute, Ottawa, ON, Canada

Read our coverage of BRUISE CONTROL 2